key: cord-0800087-74xu1z5j
authors: Abraham, Rachy; McPherson, Robert L.; Dasovich, Morgan; Badiee, Mohsen; Leung, Anthony K. L.; Griffin, Diane E.
title: Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3 Macrodomain Affect Neurovirulence in Mice
date: 2020-02-11
journal: mBio
DOI: 10.1128/mbio.03253-19
sha: 54a6d0d7afc568a29f625c33187e6800b0f72087
doc_id: 800087
cord_uid: 74xu1z5j

Macrodomain (MD), a highly conserved protein fold present in a subset of plus-strand RNA viruses, binds to and hydrolyzes ADP-ribose (ADPr) from ADP-ribosylated proteins. ADPr-binding by the alphavirus nonstructural protein 3 (nsP3) MD is necessary for the initiation of virus replication in neural cells, whereas hydrolase activity facilitates replication complex amplification. To determine the importance of these activities for pathogenesis of alphavirus encephalomyelitis, mutations were introduced into the nsP3 MD of Sindbis virus (SINV), and the effects on ADPr binding and hydrolase activities, virus replication, immune responses, and disease were assessed. Elimination of ADPr-binding and hydrolase activities (G32E) severely impaired in vitro replication of SINV in neural cells and in vivo replication in the central nervous systems of 2-week-old mice with reversion to wild type (WT) (G) or selection of a less compromising change (S) during replication. SINVs with decreased binding and hydrolase activities (G32S and G32A) or with hydrolase deficiency combined with better ADPr-binding (Y114A) were less virulent than WT virus. Compared to the WT, the G32S virus replicated less well in both the brain and spinal cord, induced similar innate responses, and caused less severe disease with full recovery of survivors, whereas the Y114A virus replicated well, induced higher expression of interferon-stimulated and NF-κB-induced genes, and was cleared more slowly from the spinal cord with persistent paralysis in survivors. Therefore, MD function was important for neural cell replication both in vitro and in vivo and determined the outcome from alphavirus encephalomyelitis in mice.

114) and catalytic hydrolase loop (positions 24 and 32) to alter these MD functions. N24 is within the hydrolase loop and coordinates binding to the distal ribose, as does Y114. G32 is also in the hydrolase loop, and previous studies showed that amino acid substitutions at the equivalent of this position can fine-tune hydrolase activity (27, 41, 43, 44, 50, 57) . Purified wild-type (WT) and recombinant nsP3 MD mutant N24A, G32S, G32A, G32E, Y114A, and G32E/I113R/Y114N (triple-mutant [TM]) strains were assessed for MAR hydrolase activity ( Fig. 1A and B) and ADPr-binding ( Fig. 1C) (43, 58) .

To measure hydrolase activity, the catalytic domain of PARP10 (PARP10 CD ) was incubated with 32 P-NAD ϩ to generate 32 P-mono-ADP-ribosylated (MARylated) PARP10 CD as a substrate for incubation with buffer alone, WT, or mutant nsP3 MDs for 1 h at 37°C, followed by analysis by SDS-PAGE and autoradiography (Fig. 1A) . Autoradiographs were scanned and the ability of the mutant nsP3 MDs to remove 32 P-MAR from MARylated PARP10 CD was quantified and compared to the WT set at 100% (Fig. 1B) . N24A, G32E, and TM strains had no detectable activity, whereas the G32S mutant had 73.5%, the G32A mutant had 72%, and the Y114A mutant had 42% of WT activity.

MDs bind mono-and poly-ADP-ribosylated (PARylated) substrates through interactions with the terminal ADPr moiety (59) (60) (61) . Therefore, we reasoned that a free PAR chain labeled at the 1Љ terminus with a fluorescent probe could serve as a substrate for determining the binding affinity of the SINV nsP3 MDs for ADP-ribosylated substrates using fluorescence-based biophysical methods such as microscale thermophoresis (MST) (62) . To generate a defined PAR chain fluorescently labeled at the 1Љ terminus, we used enzymatically made PAR and cleaved it from modified proteins with alkaline hydrolysis that results in loss of the terminal phosphoribose moiety, generating a 5=-phosphate (63) . After purifying PAR to defined length with high-performance liquid chromatography (HPLC), 1-ethyl-3-(N,N-dimethylamino)isopropyl carbodiimide (EDC) coupling was used to introduce an alkyne at the 1Љ terminus of (ADPr) 18 . Cy5-azide was then conjugated to alkyne-(ADPr) 18 via Cu(I)-catalyzed cycloaddition. Cy5-(ADPr) 18 was incubated with 2-fold serial dilutions of SINV WT and mutant MDs, followed by MST analyses. From these assays, we determined that the nsP3 MD WT binds to Cy5-(ADPr) 18 with a K D of 44.49 Ϯ 2.46 M (Fig. 1C) , a value comparable to the affinity of the homologous CHIKV nsP3 MD for free ADPr (27, 43) . The affinities of SINV nsP3 MD mutants for Cy5-(ADPr) 18 , were higher for Y114A (34.81 Effects of nsP3 MD mutations on SINV replication in mouse neuronal cells. The nsP3 MD mutations were introduced into clones of the TE strain of SINV (5, 6), full-length viral RNA was transcribed and viruses recovered after transfection of RNA into BHK cells. All viruses could be rescued. To assess the effects of MD mutations on replication efficiency in mouse neuronal cells, NSC34 cells were infected (multiplicity of infection [MOI] of 10) with WT SINV and SINV with each of the nsP3 MD single mutations (N24A, G32A, G32E, G32S, and Y114A) or set of mutations (G32E/I113R/ Y114N; TM) ( Fig. 2) . Peak virus production was at 24 h for all viruses ( Fig. 2A) . At 12 h, the amount of infectious virus released was similar to WT for G32S, G32A, and N24A, whereas G32E, Y114A, and TM had produced less virus. Infectious virus production by TM was most impaired ( Fig. 2A) , and sequencing of virus from 12 and 24 h showed mutation of G32E to G32S and reversion of position 113 from R to I and position 114 from N to Y. Cells infected with G32E showed less cell death compared to cells infected with other viruses at 24 and 48 h (Fig. 2B ). Sequencing of viruses recovered at 12 and 24 h revealed that, in addition to the TM changes, G32E had reverted from E to WT G. Thus, altered MD function associated with mutation of G32 to E that eliminates hydrolase activity and ADPr-binding ( Fig. 1 ) resulted in selection for reversion to WT G or to the less impaired mutant S (Fig. 1 ) during growth in NSC34 cells. The other mutations (N24A, G32S, G32A, and Y114A) were retained during replication in neural cells.

Effects of nsP3 MD mutations on severity of SINV encephalomyelitis in mice. The TE WT strain of SINV causes fatal encephalomyelitis in 2-week-old mice (52) . To determine the role of the nsP3 MD in the pathogenesis of encephalomyelitis, we infected 2-week-old CD1 mice intracranially with 1,000 PFU of WT SINV and nsP3 MD mutants N24A, G32A, G32E, G32S, Y114A, and TM (Fig. 3) . Signs of disease appeared later (day 4) in mice infected with G32A, G32S, and TM than in mice infected with WT SINV or mutants N24A, G32E, and Y114A (day 3) (Fig. 3B ). Mice infected with WT virus developed ataxia and an abnormal gait with progressive paralysis, and all died by 9 days postinfection (mean day of death [MDOD] ϭ 6.2) (Fig. 3A) . Surprisingly, mice infected with G32E also developed fatal encephalomyelitis with a time course similar to that of WT virus-infected mice (MDOD ϭ 6), as did mice infected with N24A (84% mortality; MDOD ϭ 6.4). Disease was least severe in mice infected with G32A with 32% mortality (MDOD ϭ 9.6, P Ͻ 0.0001), G32S with 29% mortality (MDOD ϭ 8.2, P Ͻ FIG 2 Replication of SINV WT and nsP3 MD mutants in mouse neuronal NSC34 cells. NSC34 cells were infected with SINV WT (TE strain) and nsP3 MD mutants N24A, G32A, G32E, G32S, Y114A, and TM (G32E/I113R/Y114N) at an MOI of 10. (A) Virus production was measured by plaque formation in Vero cells. The data are presented as means Ϯ the SD obtained from three independent experiments *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001 (TE versus nsP3 MD mutants N24A, G32A, G32E, Y114A, and TM). (B) Cell viability after infection was determined by trypan blue exclusion. The data are presented as means Ϯ the SD obtained from three independent experiments of the numbers of viable cells compared to day 0 expressed as a percentage. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001 (G32E versus TE and nsP3 MD mutants N24A, G32A, G32S, Y114A, and TM). Significance was determined by two-way ANOVA with Tukey's multiplecomparison test. 0.0001) and TM with 30% mortality (MDOD ϭ 8.7, P Ͻ 0.0001) (Fig. 3A ). Surviving mice in these groups recovered neurologic function by 14 days after infection (Fig. 3B ). Mice infected with Y114A had an intermediate phenotype with 60% mortality (MDOD ϭ 6.8, P Ͻ 0.001) (Fig. 3A) , and surviving mice had persistent hind limb paralysis (Fig. 3B ) despite a gain in body weight that was similar to that of G32S and G32A survivors (Fig. 3C ).

To determine whether viruses reverted or developed compensatory mutations during in vivo CNS replication, the MDs of recovered viruses were sequenced. As observed during replication in NSC34 cells, G32E reverted to WT G and TM mutated to G32S and reverted to 113I and 114Y, while N24A retained this mutation. Thus, the two viruses with the G32E MD mutation were rapidly selected against during growth in neural cells both in vitro and in vivo. For G32E, reversion to G conferred WT virulence in mice, while selection of G32S in TM, along with reversion of position 113 to I and position 114 to Y led to virulence similar to single mutant G32S (Fig. 3A) . Viruses with other MD mutations were less neurovirulent than WT but differed in whether survivors recovered neurologic function. Because G32E and TM reverted, N24A had been studied previously (55) , and G32S and G32A had similar phenotypes, subsequent studies focused on comparisons between WT, G32S (decreased binding and hydrolase) and Y114A (increased binding and decreased hydrolase).

To determine the effect of nsP3 MD mutations on virus replication and clearance from the CNS, brain and spinal cord homogenates were assayed for SINV by plaque assay and for viral RNA by quantitative reverse transcription-PCR (qRT-PCR) (Fig. 4) . In brain, all three viruses had similarly high levels of infectious virus 2 days after infection but differed in clearance (Fig. 4A) . G32S was cleared more rapidly than WT (P Ͻ 0.05, day 4), while Y114A was cleared more slowly than WT (P Ͻ 0.05, day 6). In the spinal cord, the amount of virus at day 2 was lower for G32S than for the WT and Y114A (P Ͻ 0.0001), and the clearance of infectious virus occurred earlier (day 6). Y114A had titers similar to WT through day 4, but the amounts of infectious virus remained high at day 6 (P Ͻ 0.0001, WT versus Y114A) (Fig. 4B) . SINV genomic and subgenomic RNAs were quantified in the brains ( Fig. 4C and E) and spinal cords ( Fig. 4D and F) as determined by qRT-PCR using primers specific for nsP2 (genomic; Fig. 4E and F) and E2 (subgenomic and genomic; Fig. 4C and D). The levels of viral RNA were generally lower for G32S than for the WT in both the brain and spinal cord at all times after infection, while the levels of Y114A were similar or higher than the WT. Therefore, replication of G32S in the CNS was impaired compared to the WT with rapid clearance, whereas the replication of Y114A was similar to the WT, but with impaired clearance.

Effects of nsP3 MD mutations on expression of Parp mRNAs in the CNS. Several PARPs are under diversifying evolutionary pressure, are induced by IFN, and/or have demonstrated antiviral activity, suggesting that MD function may be important for countering the antiviral effects of ADP-ribosylated proteins (46, 50, 51, 64, 65) . In addition, although Parp mRNAs are not induced by infection of NSC34 cells, PARPs are activated for ADP-ribosylation and facilitate CHIKV replication (37) . To determine whether Parp mRNA expression was induced by CNS infection, we measured changes in levels of selected Parp mRNAs in brain and spinal cord by qRT-PCR ( Fig. 5A and B) . Expression of Parp1 mRNA changed little, but mRNAs for Parp9, -10, -12, -13, and -14 were increased by infection. At 2 days after infection, the brain levels of Parp9, -10, -12, -13, and -14 mRNAs and the spinal cord levels of Parp14 mRNA were higher in Y114A-infected mice than in either WT or G32S-infected mice. To determine whether PARP14 protein levels were increased after infection, brain and spinal cord homogenates were probed by immunoblotting ( Fig. 5C and D). PARP14 protein levels increased in the CNS after infection with all three viruses with higher levels at 4 days (P Ͻ 0.0001 versus WT/G32S) and lower levels at 6 days (P Ͻ 0.05 versus WT, P Ͻ 0.0001 versus G32S) in the brains of Y114A-infected mice. Therefore, a subset of Parp mRNAs was increased after infection with generally higher levels induced by Y114A than WT or G32S infection.

Effects of nsP3 MD mutations on IFN pathway activation in the CNS. Because Parp9, -10, -12, -13, and -14 are IFN inducible (46, (66) (67) (68) (69) (70) , the MD-mediated regulation of innate responses was examined further (Fig. 6 ). The expression of mRNAs for Rig-I and Mda5, important cytoplasmic sensors of viral RNAs, was analyzed in the brains and spinal cords of infected mice by qRT-PCR (Fig. 6A ). Rig-I and Mda5 were induced in all groups with higher levels of both mRNAs at day 2 in the brains of Y114A compared to WT-or G32S-infected mice (P Ͻ 0.0001), but with similar levels in the spinal cord. To compare levels of type I IFNs in the CNS after infection, the levels of alpha interferon (IFN-␣) and IFN-␤ protein in homogenates of the brain and spinal cord were assessed by enzyme immunoassay (EIA) (Fig. 6B) . WT virus induced more IFN than either Y114A or G32S (P Ͻ 0.05 versus Y114A, P Ͻ 0.001 versus G32S IFN-␣ day 2 brain; P Ͻ 0.001 versus G32S IFN-␣ day 6 spinal cord; P Ͻ 0.0001 versus G32S IFN-␤ day 2 and P Ͻ 0.0001 versus G32S/Y114A IFN-␤ day 4 spinal cord). Therefore, infection with WT SINV FIG 4 Infectious virus and SINV RNA in brains and spinal cords of mice infected with WT and nsP3 MD mutants. Two-week-old CD-1 mice were inoculated intracranially with 1,000 PFU of SINV WT or nsP3 MD mutants G32S and Y114A. Brain (A) and spinal cord (B) homogenates from four mice from each group at each time point were assayed for infectious virus by plaque assay. RNA extracted from brain and spinal cord tissues was assayed for viral subgenomic and genomic (C and D) and genomic (E and F) RNA by qRT-PCR. Data pooled from two independent experiments are presented as means Ϯ the SD for eight mice for each time point per group. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. *, P Ͻ 0.05; ****, P Ͻ 0.0001 (WT versus G32S).^, P Ͻ 0.05;^^^^, P Ͻ 0.0001 (WT versus or Y114A). #, P Ͻ 0.05; ##, P Ͻ 0.01; ###, P Ͻ 0.001; ####, P Ͻ 0.0001 (G32S versus Y114A).

Alphavirus Neurovirulence in Mice ® induced more brain IFN, but the expression of Parps, Rig-I, and Mda5 IFN-stimulated genes (ISGs) was highest in response to Y114A infection.

To assess potential differences in IFN signaling, expression and phosphorylation of STAT1, an important cytoplasmic transcription factor activated by Jak kinase-mediated tyrosine phosphorylation in response to IFN (71, 72) , was examined by immunoblotting brain and spinal cord homogenates (Fig. 7A to D) . CNS expression of STAT1 protein was increased in response to infection by all three viruses. Activation of STAT1 (pSTAT1) in FIG 5 Modulation of PARP mRNA and protein expression in the CNS of mice infected with WT and nsP3 MD mutants. Two-week-old CD-1 mice were inoculated intracranially with 1,000 PFU of SINV WT (TE) or nsP3 MD mutants G32S and Y114A. RNA was extracted from brain and spinal cord tissues and the expression of Parp1, Parp9, Parp10, and Parp12 (A) and of Parp13 and Parp14 (B) (upper panels, brain; lower panels, spinal cord) mRNAs were measured by qRT-PCR. C T values were normalized to Gapdh, and the fold change was calculated relative to samples from day 0 (ΔΔC T ). Data pooled from two independent experiments are presented as means Ϯ the SD for eight mice per group. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001 (WT versus G32S).^, P Ͻ 0.05;^^, P Ͻ 0.01;^^^^, P Ͻ 0.0001 (WT versus Y114A). #, P Ͻ 0.05; ##, P Ͻ 0.01; ###, P Ͻ 0.001; ####, P Ͻ 0.0001 (G32S versus Y114A). (C) Immunoblots of brain and spinal cord homogenates (20 g of 10% [wt/vol]) probed for PARP14. Antibody against ␤-actin was used for loading controls. The levels of PARP14 (170-kDa band) relative to actin in the brain (upper panel) and spinal cord (lower panel) were determined using densitometry from five blots for brain and four blots for spinal cord and presented as a bar graph. Significance was determined by 2-way ANOVA with Tukey's multiple-comparison test.^, P Ͻ 0.05;^^^^, P Ͻ 0.0001 (WT versus Y114A). ####, P Ͻ 0.0001 (G32S versus Y114A). (D) Representative immunoblot images of brain (upper) and spinal cord (lower) homogenates probed for PARP14 and actin. were probed for total and phosphorylated STAT1. Antibody against ␤-actin was used for loading controls. The levels of pSTAT1 (Y701) and STAT1 (91-ϩ 84-kDa band) relative to the actin in brain (A) and spinal cord (C) were quantitated using densitometry from five blots and are presented as a bar graph. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. *, P Ͻ 0.05 (WT versus G32S). ##, P Ͻ 0.01 (G32S versus Y114A). Representative immunoblot images of brain (B) and spinal cord (D) homogenates probed for pSTAT1, STAT1, and actin. (E) RNA extracted from brain and spinal cord tissues assayed for mRNA expression of Ifit1, Ifit2, and Isg15 by qRT-PCR. C T values were normalized to Gapdh, and the fold change was calculated relative to infected controls at day 0 (ΔΔC T ). Data pooled from two independent experiments are presented as means Ϯ the SD for eight mice for each time point per group. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001 (WT versus G32S).^, P Ͻ 0.05;^^^, P Ͻ 0.001;^^^^, P Ͻ 0.0001 (WT versus Y114A). #, P Ͻ 0.05; ##, P Ͻ 0.01; ###, P Ͻ 0.001; ####, P Ͻ 0.0001 (G32S versus Y114A). brain was evident by 2 days after infection, with lower levels for G32S-infected mice (day 2 P Ͻ 0.05 versus WT, day 6 P Ͻ 0.01 versus Y114A) (Fig. 7A to D) , but no differences in the spinal cord were detected.

To further assess induction of ISGs, changes in levels of mRNAs for IFN-induced protein with tetratricopeptide repeat 1 (Ifit1), Ifit2, and Isg15 were measured (Fig. 7E) . At 2 days after infection, the levels of Ifit1 mRNA were higher in the brains (P Ͻ 0.0001 versus WT/G32S) and spinal cords (P Ͻ 0.001 versus WT, P Ͻ 0.0001 versus G32S) of mice infected with Y114A. The level of Ifit2 mRNA was also higher in the brains of Y114A-infected mice at 2 days (P Ͻ 0.05 versus WT, P Ͻ 0.0001 versus G32S) and remained at this level at 6 days in both brains (P Ͻ 0.05 versus WT/G32S) and spinal cords (P Ͻ 0.0001 versus WT/G32S). Isg15 mRNA was higher in brains of WT-and Y114A-infected mice than G32S-infected mice throughout the infection and in the spinal cord at 4 days (P Ͻ 0.0001). Therefore, although IFN levels in the brain were highest with WT infection (Fig. 6B) , Y114A generally induced a more vigorous and sustained ISG response than G32S or WT virus infection (Fig. 5, 6A, and 7) , perhaps associated with the generally higher levels and slower clearance of viral RNA (Fig. 4) .

Because NF-B pathway activation is an important component of the innate response to viral infection that occurs in response to signaling through Toll-like receptors (TLRs), we assessed the changes in the expression of the mRNAs for endosomal TLRs 3, 7, 8, and 9 that were most relevant for responses to viral infection (Fig. 8A ). All endosomal Tlr mRNAs were increased after infection. Tlr3 mRNA was most rapidly induced (day 2) and more highly expressed in the brains (P Ͻ 0.01 versus WT, P Ͻ 0.001 versus G32S) and spinal cords (P Ͻ 0.05) of mice infected with Y114A than in mice infected with WT or G32S. At 6 days after infection, the levels of Tlr7 and Tlr8 in both the brain (P Ͻ 0.0001) and the spinal cord (P Ͻ 0.01) were higher in WT-infected than in Y114A-or G32Sinfected mice.

The levels of mRNAs for several cytokines and chemokines dependent on NF-B pathway signaling were examined ( Fig. 8B and D) . Il1␤, Tnf, Il6, Ccl2, Ccl5, and Cxcl10 mRNAs were all increased in the CNS after infection. In brain, levels of all innate response gene mRNAs were generally highest at 2 days in Y114A-infected mice and lowest in G32S-infected mice. In the spinal cord, WT-infected mice had higher levels of Il6, Tnf, Ccl2, and Ccl5 mRNAs at 2 or 4 days after infection, while Il1␤ was highest in Y114A at 2 and 6 days (P Ͻ 0.01 versus G32S, P Ͻ 0.0001 versus Y114A). The levels of mRNAs for chemokines Ccl2, Ccl5, and Cxcl10 remained higher at 6 days after infection in spinal cords of Y114A-infected than WT-infected mice (P Ͻ 0.0001) ( Fig. 8B and D) . The levels of tumor necrosis factor alpha (TNF-␣) protein in the CNS also increased after infection and were higher in WT-infected mice at 2 days postinfection in the brain (P Ͻ 0.05 versus Y114A, P Ͻ 0.001 versus G32S) and remained high in the spinal cords of Y114A-infected mice at 8 days (P Ͻ 0.0001) (Fig. 8C) . Therefore, Y114A-infected mice tended to have higher early levels of these cytokine and chemokine mRNAs in brain than WT mice and persistent expression in spinal cord, whereas the responses of G32S-infected mice were generally lower than WT-infected mice.

To determine the effects of MD mutations on induction of the adaptive immune response, we measured the levels of SINV-specific antibodies in the serum (Fig. 9A) , brains (Fig. 9B ) and spinal cords (Fig. 9C ) of mice infected with WT, G32S, and Y114A viruses by EIA. Serum levels of SINV-specific IgM were lower for Y114A (P Ͻ 0.01 days 4 and 6) than G32S and WT (Fig. 9A) , whereas levels of IgG were lower in mice infected with G32S (P Ͻ 0.01, days 4 and 6) (Fig. 9A) . Because the antibody levels in the CNS reflect entry of antibody-secreting cells into the brain and spinal cord and are most important for virus clearance and recovery (73, 74) , we also measured SINV-specific antibodies in CNS tissue homogenates. In both the brain (Fig. 9B ) and the spinal cord (Fig. 9C ) the IgM and IgG levels were similar. These data suggest that MD mutations had little effect on induction of the antibody response to SINV. Because CD4 and CD8 T cells also play an important role in adaptive immune responses, we assessed changes in the CNS levels of Cd4, Cd8a, and Cd8b mRNAs after infection as indicators of T cell infiltration and retention (Fig. 10A) . Expression of Cd4 mRNA steadily increased, while Cd8a and Cd8b increased for 6 days and then decreased at 8 days in surviving G32S-and Y114A-infected mice. The levels of Cd4, Cd8a, and Cd8b mRNAs in the brain were similar in the three groups, but in the spinal cord at 6 days the mRNA levels of Cd4 (P Ͻ 0.0001), CD8a (P Ͻ 0.0001), and CD8b (P Ͻ 0.001) were lowest in WT-infected mice (Fig. 10A) .

Because the primary T cell effector of SINV clearance is IFN-␥ with interleukin-10 (IL-10) as an important regulator (74) (75) (76) , these cytokine mRNAs were measured as additional indicators of T cell responses in the CNS (Fig. 10B) . Ifn␥ mRNA was highly induced in all animals and, at day 6, the level was lower in the brains and spinal cords of mice infected with WT virus than in G32S (P Ͻ 0.001, brain; P Ͻ 0.0001 spinal cord)or Y114A (P Ͻ 0.05, brain; P Ͻ 0.0001, spinal cord)-infected mice (Fig. 10B) . The expression of IFN-␥-induced ISGs guanylate binding protein 1 (Gbp1) and Gbp2 mRNAs also increased in the brains and spinal cords of all mice. In the spinal cord the levels of Gbp1 and Gbp2 mRNAs at day 6 were lowest for WT-infected mice (Gbp1, P Ͻ 0.0001; Gbp2, P Ͻ 0.001). The mRNA for regulatory cytokine Il10 increased after infection, with the highest levels in the brains of WT-infected mice at 6 days (P Ͻ 0.0001) and in spinal cords at 4 days (P Ͻ 0.0001) (Fig. 10B) . These data suggest that SINV with MD mutations induce a more vigorous IFN-␥-producing T cell response to infection than WT SINV, particularly in the spinal cord.

Viral nonstructural protein MDs possess both MAR hydrolase and ADPr-binding activities (43) (44) (45) and are important determinants of neurovirulence, but how pathogenesis of alphavirus encephalomyelitis is affected by alterations in the ADPr-binding and hydrolase functions of the nsP3 MD has not been evaluated. Previous studies of CHIKV nsP3 MD mutants showed that these activities are critical for different aspects of alphavirus replication in neuronal cells (37, 43, 55) . If both functions are impaired, initiation of infection is inefficient, and little if any virus is produced. If there is better binding but diminished hydrolase activity, replication is initiated more quickly, but the amplification of replication complexes is impaired (37) . To determine how altered MD functions affect the pathogenesis of encephalomyelitis, we introduced mutations similar to those studied in CHIKV into SINV, a better model system for analysis of CNS alphavirus infection in mice, and showed that the effects on ADPr-binding and hydrolase activities were similar to those observed for CHIKV.

In vitro replication of SINV in neural cells and in vivo replication in the CNS of mice were severely impaired by mutations that eliminate ADPr-binding and hydrolase activities (G32E) with reversion to WT (G) or selection of a less compromising change (S) during replication. SINVs with MDs deficient in both binding and hydrolase activities (G32S and G32A) or with hydrolase deficiency combined with better binding (Y114A) were less virulent than WT virus in mice but displayed different phenotypes. G32S replicated less well in both the brain and the spinal cord, induced similar innate from brain and spinal cord tissues and mRNA expression of Tlr3, Tlr7, Tlr8, and Tlr9 (A) and Il6, Il1␤, and Tnf (B) was measured by qRT-PCR (upper panels, brain; lower panels, spinal cord). The C T values were normalized to Gapdh, and the fold change was calculated relative to day 0 (ΔΔC T ). Data pooled from two independent experiments are presented as means Ϯ the SD for eight mice for each time point per group. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. (C) Brain (upper panel) and spinal cord (lower panel) homogenates were tested by EIA for TNF-␣. Graphs show the average concentration of TNF-␣ in pg/g tissue from four animals per group. The dotted line indicates the lowest assay range value in pg/ml. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. (D) Expression of Ccl2, Ccl5, and Cxcl10 mRNAs (upper panels, brain; lower panels, spinal cord) was measured by qRT-PCR. The C T values were normalized to Gapdh, and the fold change was calculated relative to day 0 (ΔΔC T ). Data pooled from two independent experiments are presented as means Ϯ the SD for eight mice per group for each time point. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001 (WT versus G32S).^, P Ͻ 0.05;^^, P Ͻ 0.01;^^^, P Ͻ 0.001;^^^^, P Ͻ 0.0001 (WT versus Y114A). #, P Ͻ 0.05; ##, P Ͻ 0.01; ###, P Ͻ 0.001; ####, P Ͻ 0.0001 (G32S versus Y114A).

Alphavirus Neurovirulence in Mice ® immune responses, and caused less severe disease, with 71% survival and full recovery of survivors. Y114A replicated better than WT and induced higher expression of IFN-stimulated and NF-B-induced genes with similar antibody responses but was cleared more slowly from the spinal cord, with 40% survival and persistent neurologic deficits in survivors. Therefore, MD function was important for neural cell replication both in vitro and in vivo and determined the outcome from alphavirus encephalomyelitis in mice.

Alanine substitution at residue 10 eliminates alphavirus MD ADPr-binding and is not tolerated by CHIKV (D10) or by SINV (N10), and D is present at this position in the encephalitic New World alphaviruses VEEV, EEEV, and WEEV (43, 55) . Mutation of this critical binding residue leads to a failure to synthesize viral RNA in neural cells, so that any virus recovered had either reverted to D, T, or N or acquired a compensatory mutation at position 31 (E to G) (37, 55) . The hydrolase loop formed by residues 24 to 33 also participates in ADPr-binding (necessary for enzyme function), but enzymatic activity per se is less critical for initiating alphavirus replication (37) . The amino acid at position 24 (N) is conserved in all viral MDs examined (50, 51) , and mutation of N24 to FIG 9 Antibody responses of mice infected with WT and nsP3 MD mutants. Two-week-old CD-1 mice were inoculated intracranially with 1,000 PFU of SINV TE and nsP3 MD mutants G32S and Y114A. Serum (A), brain (B), and spinal cord (C) homogenates were tested for SINV-specific IgM (left panels) and IgG (right panels) by EIA. The graphs show the OD of serum (1:100 dilution) and 10% (wt/vol) brain and spinal cord homogenates (1:2 dilution) from four animals per group. Significance was determined by multiple Student t tests using the Holm-Sidak method. *, P Ͻ 0.05; **, P Ͻ 0.01 (WT versus G32S).^, P Ͻ 0.05;^^, P Ͻ 0.01 (WT versus G32S versus Y114A). ##, P Ͻ 0.01 (G32S versus Y114A).

A eliminated hydrolase activity (Fig. 1) and impairs shutoff host protein synthesis in NIH 3T3 cells (56) but did not affect replication in NSC34 cells ( Fig. 2A) . However, mortality in 2-week-old mice was reduced from 100 to 84% in the present study (Fig. 3A) and to 40% in our previous study (55) and is associated with more rapid virus clearance. The reasons for differences in mortality between the two studies are not known but may be due to differences in genetic background or microbiome composition of outbred CD-1 mice. The phenotype was similar to that observed with mutation at the comparable position of the SARS-CoV MD (N41A/N1040A) that does not affect replication in Vero or FIG 10 Cellular immune response genes expressed by mice infected with WT and nsP3 MD mutants. Expression of Ifn␥, Il10, and IFN-␥-induced ISG mRNAs in the CNS of mice infected with WT and nsP3 MD mutants. Two-week-old CD-1 mice were inoculated intracranially with 1,000 PFU of SINV TE or nsP3 MD mutants G32S and Y114A. RNA was extracted from brain and spinal cord tissues, and the mRNAs for Cd4, Cd8a, and Cd8b (A) and Ifn␥, Il10, Gbp1, and Gbp2 (B) were measured by qRT-PCR (upper panels, brain; lower panels, spinal cord). The C T values were normalized to Gapdh, and the fold change was calculated relative to day 0 (ΔΔC T ). Data pooled from two independent experiments are presented as means Ϯ the SD for eight mice for each time point per group. Significance was determined by two-way ANOVA with Tukey's multiple-comparison test. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001 (WT versus G32S).^, P Ͻ 0.05;^^, P Ͻ 0.01;^^^, P Ͻ 0.001;^^^^, P Ͻ 0.0001 (WT versus Y114A). #, P Ͻ 0.05; ##, P Ͻ 0.01; ####, P Ͻ 0.0001 (G32S versus Y114A).

Alphavirus Neurovirulence in Mice ® Calu-3 2B4 epithelial cells but decreases lung virus replication and improves survival of mice after respiratory infection. These results were postulated to be linked to MD regulation of innate response genes with higher lung levels of IFN, ISG, IL-6 and TNF mRNAs at 24 h, but not 72 h, after infection (40) . The specific mechanisms for these effects have yet to be identified.

The amino acid at position 32 is a critical determinant of binding, as well as enzymatic, activity, and G is highly conserved for all viral MDs, including the encephalitic alphaviruses VEEV, WEEV, and EEEV (51) . E at this position eliminates both binding and hydrolase activities (Fig. 1) (43) , and SINV G32E MD mutants reverted during replication in NSC34 cells and in the nervous systems of mice. Mutation of G32 to S or A partially preserved ADPr-binding, with hydrolase activity decreased 26.5% for G32S and 28% for G32A (Fig. 1) . These viruses replicated less well in NSC34 cells than did the WT (Fig. 2) and induced less severe neurologic disease with reduced mortality in mice (Fig. 3) . Replication of G32S in the CNS was lower than that of the WT, with the most striking difference in the spinal cord (Fig. 4) . We postulate that decreased virus production is due to less efficient initiation and amplification of replication in neurons, as observed in vitro for CHIKV G32S (37) , resulting in decreased spread of virus to the spinal cord. Therefore, efficient replication complex formation and amplification in neurons likely requires binding to one or more yet to be identified ADP-ribosylated proteins.

The affinity of MD binding to ADPr is determined in part by the amino acid at position 114 in the ADPr-binding pocket (50) . The amino acid at 114 is more variable in alphaviruses than the other residues studied with a Y in EEEV and WEEV, as well as SINV and CHIKV, but F in VEEV. The Y114A substitution in SINV increases binding while decreasing hydrolase activity ( Fig. 1) (43) and thus provides an opportunity to independently examine the role of MD hydrolase activity in pathogenesis. As for CHIKV (37, 43) , SINV Y114A grew more slowly in NSC34 cells (Fig. 2) and was less virulent in mice (Fig. 3) . However, Y114A replicated as well or better than WT SINV in the CNS, was cleared more slowly from both brain and spinal cord, and resulted in permanent neurologic damage in survivors (Fig. 4) . Initial control of SINV replication in the CNS is dependent on the innate immune response, particularly local production of type I IFN (77) (78) (79) . Because viral MDs can influence both the induction of and the response to innate immune effectors (40, 65, 80, 81) , we assessed multiple parameters of the immune response to SINV in the CNSs of infected mice. Mice infected with Y114A in general had similar CNS levels of IFN-␣ and IFN-␤ and greater induction of ISGs Parp9, -10, -12, -13, and -14; Ifit1 and -2; and Isg15 ( Fig. 5 and 7) and innate response genes Tlr3, Il1␤, Il6, Tnf, Ccl2, Ccl5, and Cxcl10 (Fig. 8 ) compared to WT-infected mice. Because these same parameters tended to be lower in G32S-infected mice where viral RNA loads were also lower than WT, we postulate that MD-determined levels of virus replication in the CNS have a more important role in regulating innate responses than direct MD regulation of these responses.

Surviving Y114A-infected animals had persistent hind limb paralysis associated with delayed virus clearance from the spinal cord ( Fig. 3B and 4D ). SINV clearance is mediated by the adaptive immune response with the combined effects of antibody and IFN-␥ (74, 75, 82, 83) . Although production of serum IgM was decreased in Y114Ainfected animals compared to WT and G32S-infected mice, levels of SINV-specific IgM and IgG, as well as Ifn␥ mRNA, in the brains and spinal cords were similar or higher ( Fig. 9 and 10) . Therefore, defects in clearance could not be ascribed to failure to induce an adaptive immune response. Because the mechanisms of antibody-mediated and IFN-␥-mediated clearance of virus from neurons are not known and MD hydrolase activity affects amplification of replication complexes, shutoff of host protein synthesis and translation of structural proteins (37) , it is possible that MD interactions with intracellular mechanisms of virus clearance are affected by the mutations studied.

In summary, these studies have shown that MD function is an important determinant of alphavirus replication in the CNS, manifestations of encephalomyelitis, virus clearance, and recovery.

developed using an Amersham ECL Plus Western blot developing kit (GE Healthcare), and densitometric analysis was carried out using ImageJ software.

Statistical analysis. Survival was assessed using Kaplan-Meier curves and a log-rank (Mantel-Cox) test. Time course studies were analyzed using two-way analysis of variance (ANOVA) with Tukey's multiple-comparison posttest to compare the groups infected with TE, G32S, and Y114A 0 to 6 days after infection. Two-way ANOVA with Bonferroni's posttest was used to compare surviving G32S and Y114A groups at 8 days. Differences in a single group were determined using one-way ANOVA with Dunnett's multiple-comparison test. Differences between groups at a single time point were determined using an unpaired two-tailed Student t test with a 95% confidence interval. The results are expressed as means Ϯ the SD. Statistical analyses were conducted using Prism 8 (GraphPad).

Prolonged myalgia in Sindbis virus infection: case description and in vitro infection of myotubes and myoblasts

Chikungunya: evolutionary history and recent epidemic spread

Western equine encephalitis in infants; a report on three cases with sequelae

The economic burden imposed by a residual case of eastern encephalitis

Molecular basis of Sindbis virus neurovirulence in mice

Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein

Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells

Molecular determinants of alphavirus neuropathogenesis in mice

Amino acid mutations in the replicase protein nsP3 of Semliki Forest virus cumulatively affect neurovirulence

Differences in processing determinants of nonstructural polyprotein and in the sequence of nonstructural protein 3 affect neurovirulence of Semliki Forest virus

The enigmatic alphavirus nonstructural protein 3 (nsP3) revealing its secrets at last

Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography

SH3 domain-mediated recruitment of host cell amphiphysins by alphavirus nsP3 promotes viral RNA replication

Alphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes

Interaction of Sindbis virus nonstructural protein 3 with poly(ADP-ribose) polymerase 1 in neuronal cells

Viral and cellular proteins containing FGDF motifs bind G3BP to block stress granule formation

New World and Old World alphaviruses have evolved to exploit different components of stress granules, FXR and G3BP proteins, for assembly of viral replication complexes

Hypervariable domain of eastern equine encephalitis virus nsP3 redundantly utilizes multiple cellular proteins for replication complex assembly

Genetic analysis of the nsP3 region of Sindbis virus: evidence for roles in minus-strand and subgenomic RNA synthesis

Alphavirus nsP3 functions to form replication complexes transcribing negative-strand RNA

Structural and functional insights into alphavirus polyprotein processing and pathogenesis

Multiple roles of the nonstructural protein 3 (nsP3) alphavirus unique domain (AUD) during Chikungunya virus genome replication and transcription

NMR study of nonstructural proteins. III. 1 H, 13 C, 15 N backbone and side-chain resonance assignment of macro domain from Chikungunya virus (CHIKV)

NMR study of nonstructural proteins. I. 1 H, 13 C, 15 N backbone and side-chain resonance assignment of macro domain from Mayaro virus (MAYV. )

Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses

Macrodomains: structure, function, evolution, and catalytic activities

The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket

Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains

Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites

Toward a unified nomenclature for mammalian ADP-ribosyltransferases

New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases

ADP-ribosylation

Regulation of NF-B signaling by the mono-ADPribosyltransferase ARTD10

Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi-and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha-, and coronaviruses

The hepatitis E virus ORF1 'X-domain' residues form a putative macrodomain protein/Appr-1Љ-pase catalytic-site, critical for viral RNA replication

ADP-ribosyl-binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication

Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1Љ-phosphatase, a viral function conserved in the alpha-like supergroup

The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis

The conserved coronavirus macrodomain promotes virulence and suppresses the innate immune response during severe acute respiratory syndrome coronavirus infection

A family of macrodomain proteins reverses cellular mono-ADP-ribosylation

ADPribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence

Viral macro domains reverse protein ADP-ribosylation

The conserved macrodomains of the nonstructural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADPribosylhydrolases

New PARP gene with an anti-alphavirus function

Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts

Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein

The broad-spectrum antiviral protein ZAP restricts human retrotransposition

Macrodomain ADPribosylhydrolase and the pathogenesis of infectious diseases

Viral macrodomains: unique mediators of viral replication and pathogenesis

Viral determinants of age-dependent virulence of Sindbis virus for mice

Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis

The immune response in viral encephalitis

The nsP3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice

Sindbis virus infection causes cell death by nsP2-induced transcriptional shutoff or by nsP3-dependent translational shutoff

Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and Venezuelan equine encephalitis viruses: molecular dynamics simulations and free energy calculations

Synthesis and macrodomain binding of mono-ADP-ribosylated peptides

The macro domain is an ADP-ribose binding module

Splicing regulates NAD metabolite binding to histone macroH2A

A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation

Proteinbinding assays in biological liquids using microscale thermophoresis

Large-scale preparation and characterization of poly(ADP-ribose) and defined length polymers

Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein

The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression

Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses

Identification and characterization of interferon-induced proteins that inhibit alphavirus replication

Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication

PARP12, an interferon-stimulated gene involved in the control of protein translation and inflammation

Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-B-independent

Type 1 interferons and the virus-host relationship: a lesson in detente

Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein

Death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection

Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system

Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons

T cell-derived interleukin-10 is an important regulator of the Th17 response during lethal alphavirus encephalomyelitis

Control of Sindbis virus infection by antibody in interferon-deficient mice

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism

Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons

The ADP-ribose-1Љ-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses

Hepatitis E virus inhibits type I interferon induction by ORF1 products

Antibody-mediated clearance of alphavirus infection from neurons

Gamma interferon-dependent, noncytolytic clearance of Sindbis virus infection from neurons in vitro

Sindbis virus vector system for functional analysis of apoptosis regulators

Biotin-labeled synthetic oligodeoxyribonucleotides: chemical synthesis and uses as hybridization probes

ELTA: enzymatic labeling of terminal ADP-ribose

Neuroblastoma ϫ spinal cord (NSC) hybrid cell lines resemble developing motor neurons

Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing

Germ line IgM is sufficient, but not required, for antibodymediated alphavirus clearance from the central nervous system

Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor

This study was funded by pilot research grants from the Johns Hopkins University We thank Debra Hauer for help with multiple aspects of this project, Timothy Mitchison for the PAR mixture, Cynthia Wolberger for the use of MST equipment, Neil Cashman for NSC34 cells, and Mark Boothby for the antibody to PARP14.

Cell culture and quantification of infectious virus. NSC34 mouse neuronal cells (87, 88) and BHK-21 cells were grown in Dulbecco modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 g/ml) (Gibco/Life Technologies) at 37°C in a 5% CO 2 incubator. NSC34 cells were infected at an MOI of 10 in DMEM with 1% FBS, followed by incubation at 37°C. Virus production was measured by plaque assay on BHK-21 cells. Cell viability was determined by trypan blue exclusion.Animals and infection. Female CD-1 mice with 10-day-old litters were purchased from Charles River Laboratories (Wilmington, MA) and housed in a specific-pathogen-free animal facility at the Johns Hopkins School of Public Health. At 14 days of age, mice were lightly anesthetized with isoflurane and infected intracranially with 10 3 PFU of virus diluted in 10 l of PBS. All pups within a litter were infected with the same virus. Mice were weighed and monitored for signs of disease twice daily for 14 days. The following clinical number scoring system was used: 0, clinically normal; 1, ataxia and abnormal gait and tail posture; 2, hunched posture with occasional hind limb rearing (abnormal gait but normal locomotor activity); 3, severe hunched posture with limited to no locomotor activity (hind limb paralysis); and 4, death. For tissue collections, mice were anesthetized with an overdose of isoflurane, bled via cardiac puncture, and perfused with ice-cold PBS. Brains and spinal cords were collected and used fresh or snap-frozen and stored at -80°C.To assess the virus replication in the CNS, left brain hemispheres (20% [wt/vol]) or whole spinal cords (10% [wt/vol]) from infected mice were homogenized in Lysing Matrix A tubes at 6.0 M/s for 40 s using a FastPrep-24 homogenizer (MP Biomedicals) and clarified by centrifugation at 13,200 rpm for 15 min at 4°C. The amount of infectious virus in clarified homogenates was determined by plaque formation on BHK-21 cells. The data are plotted as mean log 10 values of PFU per g of tissue, and samples with no detectable plaques at the lowest dilution tested were assigned a value of half the limit of detection.All experiments were performed according to protocols approved by the Johns Hopkins University Animal Care and Use Committee and carried out with strict adherence to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals.RNA isolation from tissue homogenates and quantification by qRT-PCR. Right brain hemispheres or whole spinal cords from eight animals per group per time point (from two independent experiments) were homogenized in 1 ml of Qiazol reagent in lysing matrix D tubes at 6.0 M/s for 40 s using a FastPrep-24 homogenizer (MP Biomedicals), and RNA was isolated using an RNeasy Lipid Mini RNA isolation kit (Qiagen). Briefly, cDNA was synthesized with random primers using a high-capacity cDNA reverse transcription kit (Life Technologies), and qRT-PCR was performed using TaqMan gene expression arrays (Integrated DNA Technologies), and Universal PCR Master mix (Applied Biosystems). The TaqMan gene expression arrays used were: Cd4, Cd8a, Cd8b, Ifn␥, Il1␤, Il6, Tnf, Ccl2, Ccl5, Cxcl10, Tlr3, Tlr7, Tlr8, Tlr9, Rig-I, Mda5, Gbp1, Gbp2, Ifit1, Ifit2, Isg15, Parp1, Parp9, Parp10, Parp12, Parp13, and Parp14. The ΔΔC T method was used to determine relative gene expression using day 0 samples and rodent Gapdh for normalization.SINV subgenomic plus genomic RNA was quantified by qRT-PCR using TaqMan probe (SINV E2 8760 5=-6-carboxyfluorescein [FAM]-CGCATACAGACTTCCGCCCAGT-6-carboxytetramethylrhodamine [TAMRA]-3=(Applied Biosystems) and primers to the SINV E2 gene (SV 8732F-5=-TGGGACGAAGCGGACGATAA-3=; SV 8805R-5=-CTGCTCCGCTTTGGTCGTAT-3=). SINV genomic RNA was quantified using TaqMan probe (SINV nsP 3317 5=-6-carboxyfluorescein (FAM)-CCATTGCCGCCGAACTCTCCC-6-carboxytetramethylrhodamine [TAMRA]-3=) and primers to the SINV nsp2 gene (SV 3374F 5=-CCGCAAGTATGGGTACGATCA-3=; SV 3454R 5=-GTGCCCTTCCCAGCTAGCT-3=). Numbers of RNA copies were determined using a standard curve made from 10-fold dilutions of a pCRII-TOPO plasmid containing the SINV genomic or subgenomic region and normalized to endogenous rodent Gapdh. The data are plotted as SINV RNA copies/10 6 copies of Gapdh.Enzyme immunoassays. SINV-specific antibody in serum and 10% (wt/vol) brain and spinal cord homogenates was measured using an in-house EIA (89) . Maxisorp 96-well plates (Thermo Scientific Nunc) were coated with 10 6 PFU/well of SINV strain TE in 50 mM NaHCO 3 (pH 9.6) at 4°C overnight. The wells were blocked with 10% FBS in PBS containing 0.05% Tween 20 (PBST) for 2 h at 37°C. Samples diluted (1:100 for serum and 1:2 for homogenates) in blocking buffer were added, followed by incubation overnight at 4°C. Bound antibodies were detected using horseradish peroxidase (HRP)-conjugated goat anti-mouse IgM or IgG (Southern Biotech) diluted 1:1,000 in PBST plus 10% FBS for 2 h at room temperature and developed using a BD OptEIA TMB substrate reagent kit with 2 M H 2 SO 4 as the stop solution. Plates were read at 450 nm, and the optical density (OD) values from control wells were subtracted from the OD values for infected mice.IFN-␣, IFN-␤, and TNF-␣ levels in brain and spinal cord homogenates (10% wt/vol) were measured using commercial ELISA kits (PBL Assay Science; Invitrogen) according to the manufacturer's instructions. Samples from four mice per group per time point were tested in duplicate, and data are presented as pg per ml. The assay range was 12.5 to 400 pg/ml for IFN-␣, 15.6 to 1,000 pg/ml for IFN-␤, and 8 to 1,000 pg/ml for TNF-␣.Immunoblot analyses. Total protein in 10% (wt/vol) brain and spinal cord homogenates was quantified with the DC assay (Bio-Rad), and 20 g was used for SDS-PAGE on a 10% polyacrylamide gel. The samples were electrophoresed and transferred to nitrocellulose membranes. Membranes were incubated overnight at 4°C with antibodies to STAT1, phospho-STAT1 (Cell Signaling Technology), PARP14 (kindly provided by Mark Boothby, Vanderbilt University) (90) and ␤-actin (Millipore) diluted in 5% BSA. The secondary antibodies were HRP-conjugated anti-rabbit or anti-mouse IgG (Cell Signaling) diluted 1:10,000 in 2% nonfat dry milk and incubated for 1 h at room temperature. Membranes were